| CURATE. AI: optimizing personalized medicine with artificial intelligence A Blasiak, J Khong, T Kee SLAS TECHNOLOGY: Translating Life Sciences Innovation 25 (2), 95-105, 2020 | 158 | 2020 |
| Individualizing liver transplant immunosuppression using a phenotypic personalized medicine platform A Zarrinpar, DK Lee, A Silva, N Datta, T Kee, C Eriksen, K Weigle, ... Science translational medicine 8 (333), 333ra49-333ra49, 2016 | 143 | 2016 |
| Artificial intelligence in nanomedicine D Ho, P Wang, T Kee Nanoscale Horizons 4 (2), 365-377, 2019 | 113 | 2019 |
| Modulating BET bromodomain inhibitor ZEN‐3694 and enzalutamide combination dosing in a metastatic prostate cancer patient using CURATE. AI, an artificial intelligence platform AJ Pantuck, DK Lee, T Kee, P Wang, S Lakhotia, MH Silverman, C Mathis, ... Advanced Therapeutics 1 (6), 1800104, 2018 | 104 | 2018 |
| Output-driven feedback system control platform optimizes combinatorial therapy of tuberculosis using a macrophage cell culture model A Silva, BY Lee, DL Clemens, T Kee, X Ding, CM Ho, MA Horwitz Proceedings of the national academy of sciences 113 (15), E2172-E2179, 2016 | 87 | 2016 |
| Clinical validation of a nanodiamond-embedded thermoplastic biomaterial DK Lee, T Kee, Z Liang, D Hsiou, D Miya, B Wu, E Osawa, EKH Chow, ... Proceedings of the National Academy of Sciences 114 (45), E9445-E9454, 2017 | 72 | 2017 |
| Project IDentif. AI: harnessing artificial intelligence to rapidly optimize combination therapy development for infectious disease intervention A Abdulla, B Wang, F Qian, T Kee, A Blasiak, YH Ong, L Hooi, F Parekh, ... Advanced therapeutics 3 (7), 2000034, 2020 | 62 | 2020 |
| Optimizing combination therapy for acute lymphoblastic leukemia using a phenotypic personalized medicine digital health platform: Retrospective optimization individualizes … DK Lee, VY Chang, T Kee, CM Ho, D Ho Slas Technology: Translating Life Sciences Innovation 22 (3), 276-288, 2017 | 41 | 2017 |
| Harnessing CURATE. AI as a digital therapeutics platform by identifying N‐of‐1 learning trajectory profiles T Kee, C Weiyan, A Blasiak, P Wang, JK Chong, J Chen, BTT Yeo, D Ho, ... Advanced Therapeutics 2 (9), 1900023, 2019 | 35 | 2019 |
| IDentif. AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐Cov‐2) with digital drug development A Blasiak, JJ Lim, SGK Seah, T Kee, A Remus, DH Chye, PS Wong, ... Bioengineering & translational medicine 6 (1), e10196, 2021 | 31 | 2021 |
| The IDentif. AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens A Blasiak, ATL Truong, A Remus, L Hooi, SGK Seah, P Wang, DH Chye, ... NPJ Digital Medicine 5 (1), 83, 2022 | 22 | 2022 |
| Personalised, Rational, Efficacy-Driven Cancer Drug Dosing via an Artificial Intelligence SystEm (PRECISE): A Protocol for the PRECISE CURATE.AI Pilot Clinical … BKJ Tan, CB Teo, X Tadeo, S Peng, HPL Soh, SDX Du, VWY Luo, ... Frontiers in digital health 3, 635524, 2021 | 20 | 2021 |
| CerebraLux: a low-cost, open-source, wireless probe for optogenetic stimulation R Dagnew, YY Lin, J Agatep, M Cheng, A Jann, V Quach, M Monroe, ... Neurophotonics 4 (4), 045001-045001, 2017 | 14 | 2017 |
| The role of artificial intelligence in scaling nanomedicine toward broad clinical impact J Khong, P Wang, TRX Gan, J Ng, TTL Anh, A Blasiak, T Kee, D Ho Nanoparticles for Biomedical Applications, 385-407, 2020 | 13 | 2020 |
| IDentif. AI: Artificial Intelligence Pinpoints Remdesivir in Combination with Ritonavir and Lopinavir as an Optimal Regimen Against Severe Acute Respiratory Syndrome … A Blasiak, JJ Lim, SGK Seah, T Kee, A Remus, DH Chye, PS Wong, ... medRxiv, 2020.05. 04.20088104, 2020 | 6 | 2020 |
| Engineering multifunctional nanomedicine platforms for drug delivery and imaging J Grant, M Naeim, Y Lee, D Miya, T Kee, D Ho Nanotheranostics for Cancer Applications, 319-344, 2019 | 6 | 2019 |
| Artificial Intelligence: Modulating BET Bromodomain Inhibitor ZEN‐3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient Using CURATE. AI, an … AJ Pantuck, DK Lee, T Kee, P Wang, S Lakhotia, MH Silverman, C Mathis, ... Advanced Therapeutics 1 (6), 1870020, 2018 | 6 | 2018 |
| Synthesis and characterization of nanodiamond–growth factor complexes toward applications in oral implantation and regenerative medicine JYR Bang, C Ting, P Wang, T Kim, KK Wang, T Kee, D Miya, D Ho, ... Journal of Oral Implantology 44 (3), 207-211, 2018 | 5 | 2018 |
| Abstract CT268: CURATE. AI-optimized modulation for multiple myeloma: an N-of-1 randomized trial A Blasiak, TW Kee, MBM Rashid, EKH Chow, S De Mel, WJ Chng, D Ho Cancer Research 80 (16_Supplement), CT268-CT268, 2020 | 4 | 2020 |
| CURATE. AI COR-Tx platform as a digital therapy and digital diagnostic for cognitive function in patients with brain tumour postradiotherapy treatment: protocol for a … A Remus, X Tadeo, GNS Kai, A Blasiak, T Kee, S Vijayakumar, L Nguyen, ... BMJ open 13 (10), e077219, 2023 | 2 | 2023 |
